1
|
Mourouzis K, Oikonomou E, Siasos G, Tsalamadris S, Vogiatzi G, Antonopoulos A, Fountoulakis P, Goliopoulou A, Papaioannou S, Tousoulis D. Pro-inflammatory Cytokines in Acute Coronary Syndromes. Curr Pharm Des 2020; 26:4624-4647. [PMID: 32282296 DOI: 10.2174/1381612826666200413082353] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2019] [Accepted: 04/01/2020] [Indexed: 12/12/2022]
Abstract
BACKGROUND Over the last decades, the role of inflammation and immune system activation in the initiation and progression of coronary artery disease (CAD) has been established. OBJECTIVES The study aimed to present the interplay between cytokines and their actions preceding and shortly after ACS. METHODS We searched in a systemic manner the most relevant articles to the topic of inflammation, cytokines, vulnerable plaque and myocardial infarction in MEDLINE, COCHRANE and EMBASE databases. RESULTS Different classes of cytokines (intereleukin [IL]-1 family, Tumor necrosis factor-alpha (TNF-α) family, chemokines, adipokines, interferons) are implicated in the entire process leading to destabilization of the atherosclerotic plaque, and consequently, to the incidence of myocardial infarction. Especially IL-1 and TNF-α family are involved in inflammatory cell accumulation, vulnerable plaque formation, platelet aggregation, cardiomyocyte apoptosis and adverse remodeling following the myocardial infarction. Several cytokines such as IL-6, adiponectin, interferon-γ, appear with significant prognostic value in ACS patients. Thus, research interest focuses on the modulation of inflammation in ACS to improve clinical outcomes. CONCLUSION Understanding the unique characteristics that accompany each cytokine-cytokine receptor interaction could illuminate the signaling pathways involved in plaque destabilization and indicate future treatment strategies to improve cardiovascular prognosis in ACS patients.
Collapse
Affiliation(s)
- Konstantinos Mourouzis
- 1st Department of Cardiology, 'Hippokration' Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece
| | - Evangelos Oikonomou
- 1st Department of Cardiology, 'Hippokration' Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece
| | - Gerasimos Siasos
- 1st Department of Cardiology, 'Hippokration' Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece
| | - Sotiris Tsalamadris
- 1st Department of Cardiology, 'Hippokration' Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece
| | - Georgia Vogiatzi
- 1st Department of Cardiology, 'Hippokration' Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece
| | - Alexios Antonopoulos
- 1st Department of Cardiology, 'Hippokration' Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece
| | - Petros Fountoulakis
- 1st Department of Cardiology, 'Hippokration' Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece
| | - Athina Goliopoulou
- 1st Department of Cardiology, 'Hippokration' Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece
| | - Spyridon Papaioannou
- 1st Department of Cardiology, 'Hippokration' Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece
| | - Dimitris Tousoulis
- 1st Department of Cardiology, 'Hippokration' Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece
| |
Collapse
|
2
|
Martins JD, Zachariah J, Selamet Tierney ES, Truong U, Morris SA, Kutty S, de Ferranti SD, Guarino M, Thomas B, Oliveira D, Marinho A, António M, Gauvreau K, Jalles N, Geva T, Carmo MM, Prakash A. Impact of Treatment Modality on Vascular Function in Coarctation of the Aorta: The LOVE - COARCT Study. J Am Heart Assoc 2019; 8:e011536. [PMID: 30929556 PMCID: PMC6509735 DOI: 10.1161/jaha.118.011536] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/18/2018] [Accepted: 01/31/2019] [Indexed: 01/04/2023]
Abstract
Background Optimally treated patients with coarctation of the aorta remain at risk for late vascular dysfunction. The effect of treatment modality on vascular function is unknown. The LOVE-COARCT (Long-term Outcomes and Vascular Evaluation After Successful Coarctation of the Aorta Treatment) study was done to compare vascular function in patients with coarctation of the aorta treated with surgery, balloon dilation (BD), or stent implantation. Methods and Results In treated coarctation of the aorta patients without residual coarctation, we prospectively compared aortic stiffness by applanation tonometry and cardiac magnetic resonance; endothelial function by endothelial pulse amplitude testing; blood pressure ( BP ) phenotype by office BP , ambulatory BP monitoring, and BP response to exercise; left ventricular mass by cardiac magnetic resonance; and blood biomarkers of endothelial function, inflammation, vascular wall function, and extracellular matrix. Participants included 75 patients treated with surgery (n=28), BD (n=23), or stent (n=24). Groups had similar age at enrollment, coarctation of the aorta severity, residual gradient, and metabolic profile, but differed by age at treatment. Prevalence of systemic hypertension, aortic stiffness, endothelial function, and left ventricular mass were similar among treatment groups. However, BD patients had more-distensible ascending aortas, lower peak systolic BP during exercise, less impairment in diurnal BP variation, and lower inflammatory biomarkers. Results were unchanged after adjustment for potential confounders, including age at treatment. Conclusions In our cohort of patients without residual coarctation, treatment modality was not associated with major vascular outcomes, even though there were some favorable vascular characteristics in the BD patients. Although this suggests that choice of treatment modality should continue to be driven by likelihood of achieving a good anatomical result, more long-term studies are required to assess the clinical significance of the more-optimal results of secondary markers of vascular function in BD patients. Clinical Trial Registration URL : http://www.clinicaltrials.gov . Unique identifier: NCT 03262753.
Collapse
Affiliation(s)
- José D. Martins
- Department of Pediatric CardiologyHospital de Santa MartaCentro Hospitalar de Lisboa CentralLisbonPortugal
| | - Justin Zachariah
- Division of Pediatric CardiologyDepartment of PediatricsTexas Children's Hospital and Baylor College of MedicineHoustonTX
| | - Elif Seda Selamet Tierney
- Division of Pediatric CardiologyDepartment of PediatricsLucile Packard Children's Hospital and Stanford UniversityPalo AltoCA
| | - Uyen Truong
- Division of Pediatric CardiologyChildren's Hospital ColoradoDenverCO
| | - Shaine A. Morris
- Division of Pediatric CardiologyDepartment of PediatricsTexas Children's Hospital and Baylor College of MedicineHoustonTX
| | - Shelby Kutty
- Division of Pediatric CardiologyChildren's Hospital and Medical CenterOmahaNE
- University of Nebraska College of MedicineOmahaNE
| | - Sarah D. de Ferranti
- Department of CardiologyBoston Children's Hospital and Harvard Medical SchoolBostonMA
| | - Maria Guarino
- CEDOC Chronic DiseasesNova Medical SchoolLisbonPortugal
| | - Boban Thomas
- Ressonância Magnética CaselasS.A. LisbonPortugal
| | - Diana Oliveira
- Biomedical Engineering DepartmentInstituto Superior TécnicoLisbonPortugal
| | - António Marinho
- Pediatric Cardiology DepartmentHospital Pediátrico de CoimbraCoimbraPortugal
| | - Marta António
- Department of Pediatric CardiologyHospital de Santa MartaCentro Hospitalar de Lisboa CentralLisbonPortugal
| | - Kimberlee Gauvreau
- Department of CardiologyBoston Children's Hospital and Harvard Medical SchoolBostonMA
| | - Nuno Jalles
- Ressonância Magnética CaselasS.A. LisbonPortugal
| | - Tal Geva
- Department of CardiologyBoston Children's Hospital and Harvard Medical SchoolBostonMA
| | | | - Ashwin Prakash
- Department of CardiologyBoston Children's Hospital and Harvard Medical SchoolBostonMA
| | | |
Collapse
|
3
|
Zheng L, Huang D. [Effects of FTY720-P on EphA2-EphrinA2 bidirectional signaling in osteoclasts]. ZHONGGUO XIU FU CHONG JIAN WAI KE ZA ZHI = ZHONGGUO XIUFU CHONGJIAN WAIKE ZAZHI = CHINESE JOURNAL OF REPARATIVE AND RECONSTRUCTIVE SURGERY 2018; 32:575-580. [PMID: 29806345 DOI: 10.7507/1002-1892.201710109] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Objective To investigate the effects of FTY720-P on EphA2-EphrinA2 bidirectional signaling in osteoclasts. Methods Murine RAW264.7 macrophages were induced into osteoclasts by dexamethasone and 1α, 25-dihydroxyvitamin D 3, and identified by tartrate resistant acid phosphatase (TRAP) staining. Then, the osteoclasts were divided into 2 groups. The osteoclasts were treated with 400 ng/mL FTY720-P in experimental group and without FTY720-P in control group, respectively. After 48 hours of culture, the cells in 2 groups were detected by real-time fluorescent quantitative PCR, Western blot, and immunofluorescence staining. The expressions of EphA2, EphrinA2, RhoA, and the bone reconstruction associated proteins[bone morphogenetic protein 2 (BMP-2) and transform growth factor β 1 (TGF-β 1)]were analyzed and compared. Results RAW264.7 cells were successfully induced into osteoclasts identified by TRAP staining. Compared with control group, the relative expressions of EphA2 and EphrinA2 mRNAs and proteins in experimental group significantly decreased after 48 hours ( P<0.05), and the relative expression of RhoA protein also significantly decreased ( P<0.05). The relative expressions of BMP-2 and TGF-β 1 mRNAs were significantly increased ( P<0.05), and those protein expressions were enhanced. Conclusion FTY720-P can down-regulate the expression of RhoA and promote the expressions of TGF- β 1 and BMP-2 by affecting the transduction of EphA2-EphrinA2 bidirectional signaling in osteoclasts.
Collapse
Affiliation(s)
- Libin Zheng
- Guangdong Medical University, Zhanjiang Guangdong, 524023, P.R.China
| | - Dong Huang
- Guangdong Medical University, Zhanjiang Guangdong, 524023, P.R.China;Department of Trauma Orthopedics, Guangdong Second Provincial Central Hospital, Guangzhou Guangdong, 510000,
| |
Collapse
|
4
|
Martins JD, Zachariah J, Selamet Tierney ES, Truong U, Morris SA, Kutty S, de Ferranti SD, Rhodes J, Antonio M, Guarino M, Thomas B, Oliveira D, Gauvreau K, Jalles N, Geva T, Carmo M, Prakash A. Rationale and design of Long-term Outcomes and Vascular Evaluation after Successful Coarctation of the Aorta Treatment study. Ann Pediatr Cardiol 2018; 11:282-296. [PMID: 30271019 PMCID: PMC6146860 DOI: 10.4103/apc.apc_64_18] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/29/2023] Open
Abstract
Background: Coarctation of the aorta (CoA) can be treated using surgery, balloon angioplasty, or stent implantation. Although short-term results are excellent with all three treatment modalities, long-term cardiovascular (CV) morbidity and mortality remain high, likely due to persistently abnormal vascular function. The effects of treatment modality on long-term vascular function remain uncharacterized. The goal of this study is to assess vascular function in this patient population for comparison among the treatment modalities. Methods: We will prospectively assess vascular Afunction in large and small arteries fusing multiple noninvasive modalities and compare the results among the three groups of CoA patients previously treated using surgery, balloon angioplasty, or stent implantation after frequency matching for confounding variables. A comprehensive vascular function assessment protocol has been created to be used in 7 centers. Our primary outcome is arterial stiffness measured by arterial tonometry. Inclusion and exclusion criteria have been carefully established after consideration of several potential confounders. Sample size has been calculated for the primary outcome variable. Conclusion: Treatment modalities for CoA may have distinct impact on large and small arterial vascular function. The results of this study will help identify the treatment modality that is associated with the most optimal level of vascular function, which, in the long term, may reduce CV risk.
Collapse
Affiliation(s)
- Jose D Martins
- Department of Pediatric Cardiology, Hospital de Santa Marta, Centro Hospitalar de Lisboa Central, Lisbon, Portugal
| | - Justin Zachariah
- Division of Pediatric Cardiology, Texas Children's Hospital, Baylor College of Medicine, Houston, USA
| | - Elif Seda Selamet Tierney
- Division of Pediatric Cardiology, Department of Pediatrics, Lucile Packard Children's Hospital, Stanford University, Palo Alto, USA
| | - Uyen Truong
- Division of Pediatric Cardiology, Children's Hospital Colorado, Aurora, USA
| | - Shaine A Morris
- Division of Pediatric Cardiology, Texas Children's Hospital, Baylor College of Medicine, Houston, USA
| | - Shelby Kutty
- Joint Division of Pediatric Cardiology, Children's Hospital and Medical Center University of Nebraska College of Medicine, Omaha, USA
| | - Sarah D de Ferranti
- Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, USA
| | - Jonathan Rhodes
- Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, USA
| | - Marta Antonio
- Department of Pediatric Cardiology, Hospital de Santa Marta, Centro Hospitalar de Lisboa Central, Lisbon, Portugal
| | - Maria Guarino
- CEDOC Chronic Diseases, Nova Medical School, Lisbon, Portugal
| | - Boban Thomas
- Caselas, Ressonância Magnética, S. A. Lisbon, Portugal
| | - Diana Oliveira
- Biomedical Engineering Department, Instituto Superior Técnico, Lisbon, Portugal
| | - Kimberlee Gauvreau
- Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, USA
| | - Nuno Jalles
- Caselas, Ressonância Magnética, S. A. Lisbon, Portugal
| | - Tal Geva
- Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, USA
| | - Miguel Carmo
- CEDOC Chronic Diseases, Nova Medical School, Lisbon, Portugal
| | - Ashwin Prakash
- Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, USA
| |
Collapse
|
5
|
Chrysohoou C, Katsi V, Trikalinos N, Tzifa A, Alexopoulos N, Brili S, Nihoyiannopoulos P, Tousoulis D. A case of aortic arch coarctation, bicuspid aortic valve and aortic sinus aneurysm in an adult with moderate hypertension. Hellenic J Cardiol 2017; 58:69-71. [PMID: 28286131 DOI: 10.1016/j.hjc.2017.01.016] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2016] [Accepted: 09/01/2016] [Indexed: 10/20/2022] Open
Affiliation(s)
| | | | - Nikos Trikalinos
- 1st Cardiology Clinic University of Athens, Hippocratio Hospital, Greece
| | - Aphrodite Tzifa
- Congenital Heart Disease Department, Mitera Hospital, Hygeia Group, Greece
| | | | - Stella Brili
- 1st Cardiology Clinic University of Athens, Hippocratio Hospital, Greece
| | | | - Dimitris Tousoulis
- 1st Cardiology Clinic University of Athens, Hippocratio Hospital, Greece
| |
Collapse
|